Effects of green tea consumption on cognitive dysfunction in an elderly population: A randomized placebo-controlled study

Nutrition Journal

Volumn 15, Issue 1, 2016, Pages

  Ide, Kazuki ^a   Yamada, Hiroshi ^a   Takuma, Norikata ^b   Kawasaki, Yohei ^a   Harada, Shohei ^a   Nakase, Junpei ^c   Ukawa, Yuuichi ^c   Sagesaka, Yuko M ^c  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b White Cross Nursing Home   (Japan)

^c 421 0516   (Japan)

Author keywords

Cognitive function; Elderly; Green tea; Oral administration; Randomized controlled trial

Indexed keywords

CATECHIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; PLACEBO; PLANT EXTRACT; TEA;

AGED; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL; TEA; CHEMISTRY; COGNITION; COGNITIVE DYSFUNCTION; DRUG EFFECTS; JAPAN; NURSING HOME; QUESTIONNAIRE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CATECHIN; COGNITION; COGNITIVE DYSFUNCTION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; JAPAN; MALE; NURSING HOMES; OXIDATIVE STRESS; PLACEBOS; PLANT EXTRACTS; SURVEYS AND QUESTIONNAIRES; TEA;

EID: 84979066466     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/s12937-016-0168-7     Document Type: Article

References (46)

1. Sorbi S, Hort J, Erkinjuntti T, Fladby T, Gainotti G, Gurvit H, et al. EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia. Eur J Neurol. 2012;19(9):1159-79.
2. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2013;9(1):63-75.
3. Prince M, Guerchet M, Prina M. Alzheimer's disease international. Policy brief for heads of government: The global impact of dementia 2013-2050. London: Alzheimer's Disease International; 2013. https://www.alz.co.uk/research/GlobalImpactDementia2013.pdf. Accessed 27 Apr 2016.
4. Ngo J, Holroyd-Leduc JM. Systematic review of recent dementia practice guidelines. Age Ageing. 2015;44(1):25-33.
5. Schneider LS, Mangialasche F, Andreasen N, Feldman H, Giacobini E, Jones R, et al. Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014. J Intern Med. 2014;275(3):251-83.
6. Kalmijn S, Launer LJ, Ott A, Witteman JC, Hofman A, Breteler MM. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol. 1997;42(5):776-82.
7. Barberger-Gateau P, Raffaitin C, Letenneur L, Berr C, Tzourio C, Dartigues JF, et al. Dietary patterns and risk of dementia: the Three-City cohort study. Neurology. 2007;69(20):1921-30.
8. Devore EE, Grodstein F, van Rooij FJ, Hofman A, Stampfer MJ, Witteman JC, et al. Dietary antioxidants and long-term risk of dementia. Arch Neurol. 2010;67(7):819-25.
9. von Arnim CAF, Gola U, Biesalski HK. More than the sum of its parts? Nutrition in Alzheimer's disease. Nutrition. 2010;26(7-8):694-700.
10. Association A's. 2014 Alzheimer's disease facts and figures. Alzheimers Dement. 2014;10(2):e47-92.
11. Melo A, Monteiro L, Lima RM, Oliveira DM, Cerqueira MD, El-Bacha RS. Oxidative stress in neurodegenerative diseases: mechanisms and therapeutic perspectives. Oxid Med Cell Longev. 2011;2011:467180.
12. Ide K, Yamada H. Clinical benefits of green tea consumption for cognitive dysfunction. PharmaNutrition. 2015;3(4):136-45.
13. Biasibetti R, Tramontina AC, Costa AP, Dutra MF, Quincozes-Santos A, Nardin P, et al. Green tea (-)epigallocatechin-3-gallate reverses oxidative stress and reduces acetylcholinesterase activity in a streptozotocin-induced model of dementia. Behav Brain Res. 2013;236(1):186-93.
14. Srividhya R, Gayathri R, Kalaiselvi P. Impact of epigallo catechin-3-gallate on acetylcholine-acetylcholine esterase cycle in aged rat brain. Neurochem Int. 2012;60(5):517-22.
15. Coimbra S, Castro E, Rocha-Pereira P, Rebelo I, Rocha S, Santos-Silva A. The effect of green tea in oxidative stress. Clin Nutr. 2006;25(5):790-6.
16. Erba D, Riso P, Bordoni A, Foti P, Biagi PL, Testolin G. Effectiveness of moderate green tea consumption on antioxidative status and plasma lipid profile in humans. J Nutr Biochem. 2005;16(3):144-9.
17. Kuriyama S, Hozawa A, Ohmori K, Shimazu T, Matsui T, Ebihara S, et al. Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project 1. Am J Clin Nutr. 2006;83(2):355-61.
18. Ng TP, Feng L, Niti M, Kua EH, Yap KB. Tea consumption and cognitive impairment and decline in older Chinese adults. Am J Clin Nutr. 2008;88(1):224-31.
19. Feng L, Gwee X, Kua EH, Ng TP. Cognitive function and tea consumption in community dwelling older Chinese in Singapore. J Nutr Health Aging. 2010;14(6):433-8.
20. Feng L, Li J, Ng TP, Lee TS, Kua EH, Zeng Y. Tea drinking and cognitive function in oldest-old Chinese. J Nutr Health Aging. 2012;16(9):754-8.
21. Noguchi-Shinohara M, Yuki S, Dohmoto C, Ikeda Y, Samuraki M, Iwasa K, et al. Consumption of Green Tea, but Not Black Tea or Coffee, Is Associated with Reduced Risk of Cognitive Decline. PLoS One. 2014;9(5):e96013.
22. Huang CQ, Dong BR, Zhang YL, Wu HM, Liu QX. Association of cognitive impairment with smoking, alcohol consumption, tea consumption, and exercise among Chinese nonagenarians/centenarians. Cogn Behav Neurol. 2009;22(3):190-6.
23. Eskelinen MH, Ngandu T, Tuomilehto J, Soininen H, Kivipelto M. Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study. J Alzheimers Dis. 2009;16(1):85-91.
24. Arab L, Biggs ML, O'Meara ES, Longstreth WT, Crane PK, Fitzpatrick AL. Gender differences in tea, coffee, and cognitive decline in the elderly: the Cardiovascular Health Study. J Alzheimers Dis. 2011;27(3):553-66.
25. Shen W, Xiao Y, Ying X, Li S, Zhai Y, Shang X, et al. Tea consumption and cognitive impairment: a cross-sectional study among Chinese elderly. PLoS One. 2015;10(9):e0137781.
26. Ide K, Yamada H, Takuma N, Park M, Wakamiya N, Nakase J, et al. Green tea consumption affects cognitive dysfunction in the elderly: a pilot study. Nutrients. 2014;6(10):4032-42.
27. Kataoka Y, Utsunomiya K, Kimbara A, Fukushima K, Mori T, Shiba J, et al. Preventive effect of green tea containing theanine at a high concentration on dementia in aged volunteers. J Jpn Mibyou System Assoc. 2009;15:17-23 [Japanese].
28. Park SK, Jung IC, Lee WK, Lee YS, Park HK, Go HJ, et al. A Combination of Green Tea Extract and L-Theanine Improves Memory and Attention in Subjects with Mild Cognitive Impairment: a Double-Blind Placebo-Controlled Study. J Med Food. 2011;14(4):334-43.
29. Reisberg B, Jamil IA, Khan S, Monteiro I, Torossian C, Ferris S, et al. Staging dementia. In: Abou-Saleh MT, Katona C, Kumar A, editors. Principles and practice of geriatric Psychiatry. 3rd ed. Oxford: Wiley; 2011. p. 162-9.
30. Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T, et al. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci. 2000;12(2):233-9.
31. Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group. Neurology. 1998;50(1):136-45.
32. Black S, Roman GC, Geldmacher DS, Salloway S, Hecker J, Burns A, et al. Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial. Stroke. 2003;34(10):2323-30.
33. Ringman JM, Frautschy SA, Teng E, Begum AN, Bardens J, Beigi M, et al. Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study. Alzheimers Res Ther. 2012;4(5):43.
34. Fisher RA. Statistical methods for research workers. Edinburgh: Oliver & Boyd; 1934.
35. Huck SW, McLean RA. Using a repeated measures ANOVA to analyze the data from a pretest-posttest design: A potentially confusing task. Psychol Bull. 1975;82(4):511.
36. SAS/STAT(R) 14.1 User's Guide: LSMEANS Statement. http://support.sas.com/documentation/cdl/en/statug/68162/HTML/default/viewer.htm#statug-logistic-syntax20.htm. Accessed 27 Apr 2016.
37. Lin JK, Lin CL, Liang YC, Lin-Shiau SY, Juan IM. Survey of catechins, gallic acid, and methylxanthines in green, oolong, pu-erh, and black teas. J Agric Food Chem. 1998;46(9):3635-42.
38. Nakagawa S, Hoshi T, Kubo A, Yamato S. Determination of Tea polyphenols in bottled Japanese Tea drinks and differences in polyphenol content in Tea leaves from different variety. Bunseki Kagaku. 2013;62(1):51-5.
39. Park M, Yamada H, Matsushita K, Kaji S, Goto T, Okada Y, et al. Green Tea consumption is inversely associated with the incidence of influenza infection among schoolchildren in a Tea plantation area of Japan. J Nutr. 2011;141(10):1862-70.
40. Tombaugh TN. Test-retest reliable coefficients and 5-year change scores for the MMSE and 3MS. Arch Clin Neuropsychol. 2005;20(4):485-503.
41. Bennett S, Grant MM, Aldred S. Oxidative stress in vascular dementia and Alzheimer's disease: a common pathology. J Alzheimers Dis. 2009;17(2):245-57.
42. Federico A, Cardaioli E, Da Pozzo P, Formichi P, Gallus GN, Radi E. Mitochondria, oxidative stress and neurodegeneration. J Neurol Sci. 2012;322(1-2):254-62.
43. Gandhi S, Abramov AY. Mechanism of oxidative stress in neurodegeneration. Oxid Med Cell Longev. 2012;2012:428010.
44. Dasuri K, Zhang L, Keller JN. Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis. Free Radic Biol Med. 2013;62:170-85.
45. Kankaanpaa J, Turunen SP, Moilanen V, Horkko S, Remes AM. Cerebrospinal fluid antibodies to oxidized LDL are increased in Alzheimer's disease. Neurobiol Dis. 2009;33(3):467-72.
46. Nagao T, Komine Y, Soga S, Meguro S, Hase T, Tanaka Y, et al. Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde-modified LDL in men. Am J Clin Nutr. 2005;81(1):122-9.